1887
Preview this article:
Zoom in
Zoomout

infection in elderly Bulgarian patients, Page 1 of 1

| /docserver/preview/fulltext/jmm/52/12/JMM5212.1131-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/0022-1317-52-12-1131
2003-12-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/12/JM521215.html?itemId=/content/journal/jmm/10.1099/0022-1317-52-12-1131&mimeType=html&fmt=ahah

References

  1. Adamek, R. J., Suerbaum, S., Pfaffenbach, B. & Opferkuch, W. ( 1998;). Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin – influence on treatment outcome. Am J Gastroenterol 93, 386–389.
    [Google Scholar]
  2. Boyanova, L., Stancheva, I., Todorov, D. & 7 other authors ( 1996;). Comparison of three urease tests for detection of Helicobacter pylori in gastric biopsy specimens. Eur J Gastroenterol Hepatol 8, 911–914.
    [Google Scholar]
  3. Broutet, N., Tchamgoue, S., Pereira, E., Lamouliatte, H., Salamon, R. & Megraud, F. ( 2003;). Risk factors for failure of Helicobacter pylori therapy –results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 17, 99–109.[CrossRef]
    [Google Scholar]
  4. Fraser, A. G., Moore, L., Hackett, M. & Hollis, B. ( 1999;). Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit. Aust N Z J Med 29, 512–516.[CrossRef]
    [Google Scholar]
  5. Marshall, B. J. ( 1994;). Helicobacter pylori. Am J Gastroenterol 89 (Suppl.), S116–S128.
    [Google Scholar]
  6. Megraud, F., Lehn, N., Lind, T. & 7 other authors ( 1999;). Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 43, 2747–2752.
    [Google Scholar]
  7. NCCLS ( 2000;). Performance standards for antimicrobial susceptibility testing. Tenth informational supplement. Approved standard M100-S10 (M7). Wayne, PA: National Committee for Clinical Laboratory Standards.
  8. Parsons, H. K., Carter, M. J., Sanders, D. S., Winstanley, T. & Lobo, A. J. ( 2001;). Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Aliment Pharmacol Ther 15, 1473–1478.[CrossRef]
    [Google Scholar]
  9. Pilotto, A. ( 2001;). Helicobacter pylori- associated peptic ulcer disease in older patients: current management strategies. Drugs Aging 18, 487–494.[CrossRef]
    [Google Scholar]
  10. Pilotto, A. & Malfertheiner, P. ( 2002;). Review article: an approach to Helicobacter pylori infection in the elderly. Aliment Pharmacol Ther 16, 683–691.[CrossRef]
    [Google Scholar]
  11. Pilotto, A. & Salles, N. ( 2002;). Helicobacter pylori infection in geriatrics. Helicobacter 7 (Suppl. 1), 56–62.[CrossRef]
    [Google Scholar]
  12. Sargyn, M., Uygur-Bayramicli, O., Sargyn, H., Orbay, E., Yavuzer, D. & Yayla, A. ( 2003;). Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. World J Gastroenterol 9, 1126–1128.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/0022-1317-52-12-1131
Loading
/content/journal/jmm/10.1099/0022-1317-52-12-1131
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error